These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Stone NN; Hong S; Lo YC; Howard V; Stock RG Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159 [TBL] [Abstract][Full Text] [Related]
8. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices. Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787 [TBL] [Abstract][Full Text] [Related]
9. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate. Yue N; Dicker AP; Corn BW; Nath R; Waterman FM Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274 [TBL] [Abstract][Full Text] [Related]
10. Brachytherapy in patients with small prostate glands. Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802 [TBL] [Abstract][Full Text] [Related]
11. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants. Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy. Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425 [TBL] [Abstract][Full Text] [Related]
13. Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds. Sugawara A; Nakashima J; Kunieda E; Nagata H; Asakura H; Oya M; Shigematsu N Radiat Oncol; 2010 Sep; 5():86. PubMed ID: 20875137 [TBL] [Abstract][Full Text] [Related]
14. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry. Xue J; Waterman F; Handler J; Gressen E Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069 [TBL] [Abstract][Full Text] [Related]
15. Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy. Nasser NJ; Wang Y; Borg J; Saibishkumar EP Brachytherapy; 2014; 13(4):369-74. PubMed ID: 24559795 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy. Bowes D; Crook JM; Araujo C; Batchelar D Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473 [TBL] [Abstract][Full Text] [Related]
17. Examining the relationship between pre- and postimplant geometry in prostate low-dose-rate brachytherapy and its correlation with dosimetric quality using the similarity concept. Todor DA; Anscher MS; Karlin JD; Hagan MP Brachytherapy; 2014; 13(5):471-80. PubMed ID: 25037911 [TBL] [Abstract][Full Text] [Related]
18. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395 [TBL] [Abstract][Full Text] [Related]
19. Source placement error for permanent implant of the prostate. Roberson PL; Narayana V; McShan DL; Winfield RJ; McLaughlin PW Med Phys; 1997 Feb; 24(2):251-7. PubMed ID: 9048365 [TBL] [Abstract][Full Text] [Related]
20. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy. Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]